Pharmalot Ed Silverman

STAT+: After leaving patients in limbo, Pfizer agrees to sell a discontinued glaucoma drug

By Ed Silverman


Pfizer has reached a deal to sell the rights to a recently discontinued drug used by patients with a rare form of glaucoma.

Read More

STAT+: As White House mulls FDA commissioner job, a sign of industry backing for Woodcock surfaces

By Ed Silverman

Win McNamee/Getty Images

Oncologists penned a letter supporting Janet Woodcock to lead the FDA. A new analysis finds many had taken more industry money than average.

Read More

A WHO expert explains why she believes the rush for Covid-19 boosters is premature

By Helen Branswell


The agency's Kate O’Brien says she fears "we’re going to be in a place where we have forever uncertainty about what actually should be done.”

Read More

Opinion: Applying a pandemic-like response to cancer prevention

By Philip E. Castle

Jacqueline Larma/AP

Cancer prevention can be achieved by the same strategies that help prevent Covid-19: avoidance, screening, and vaccination.

Read More

Monday, August 9, 2021


Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2021, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us